Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma
- 9 March 2006
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (3) , 371-380
- https://doi.org/10.1016/j.nucmedbio.2005.12.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Contemporary Lung Cancer Trends among U.S. WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumoursJournal of Clinical Pathology, 2004
- The natural history of prostate cancerUrologic Clinics of North America, 2003
- Increased frequency of gastrin‐releasing peptide receptor gene mutations during colon‐adenocarcinoma progressionMolecular Carcinogenesis, 2003
- Technetium Labeled Bombesin-like Peptide: Preliminary Report on Breast Cancer Uptake in PatientsCancer Biotherapy & Radiopharmaceuticals, 2002
- Roles of gastrointestinal hormones in pancreatic cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancersThe Prostate, 2000
- Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancerThe Prostate, 1998
- Bombesin stimulates growth of human prostatic cancer cellsin vitroCancer, 1990
- Gastrin-Releasing Peptide Gene Expression in Developing, Hyperplastic, and Neoplastic Human Thyroid C-Cells*Endocrinology, 1988